QA: Artelo Biosciences INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621221_2019_Artelo_Biosciences_INC.pdf

Logs

warning The stock_price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001621221, Artelo Biosciences INC

  xvar xval
0 AssetsCurrent 396,435
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 563
3 remainder_Assets 0
4 LiabilitiesCurrent 531,972
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,512,002
9 ResearchAndDevelopmentExpense 1,249,854
10 remainder_Expenses 2,885,873
11 remainder_Revenues 0
12 remainder_NetIncome -1,356
13 remainder_ComprehensiveNetIncome 656
  yvar yval
0 Assets 396,998
1 Liabilities 531,972
2 Expenses 6,647,729
3 Revenues 0
4 StockholdersEquity -134,974
5 NetIncome -6,649,085
6 ComprehensiveNetIncome -6,648,757
7 BaseVar 3,789,356
8 EconomicCapitalRatiobeforeLimitedLiability -14.9
9 EconomicCapitalRatio 0.0000000243

Edgar->Model Mapping

Feature Distribution

Change over Time